News Alerts

07 Oct 2018 | 03:56 PM UTC

Brazil: Measles outbreak continues as of October 1 /update 6

Brazil News Alert

Brazilian health officials report at least 1935 confirmed cases of measles nationwide as of October 1; ensure vaccinations are current

TIMEFRAME expected from 10/5/2018, 12:00 AM until 10/12/2018, 11:59 PM (America/Sao_Paulo). COUNTRY/REGION Roraima, State of Amazonas

Read all related news alert(s):


The Brazil Ministry of Health reported on Monday, October 1, that there have been at least 1935 confirmed measles cases, including ten deaths, in an ongoing nationwide outbreak. Authorities have recorded 1525 cases in Amazonas and another 330 in Roraima. In addition, 18 cases have been reported in Rio de Janeiro and three in São Paulo.


According to health officials, the outbreak has been linked to the influx of refugees from neighboring Venezuela.

Measles is a highly contagious viral disease that typically affects mostly children. It is transmitted via droplets from the nose, mouth, or throat of infected persons. Symptoms of measles are usually a high fever, which begins approximately ten to 12 days after exposure to the virus and lasts four to seven days. A runny nose, a cough, red and watery eyes, and small white spots inside the cheeks can develop in the initial stage. After several days, a rash erupts, usually on the face and upper neck. Over the course of about three days, the rash spreads, eventually reaching the hands and feet. The rash lasts for five to six days and then fades. On average, the rash appears 14 days after exposure to the virus (within a range of seven to 18 days). A vaccine is available.


Potentially affected individuals are advised to ensure their measles vaccination is up to date (including booster shots) and to contact their doctor with any questions or concerns. Anyone experiencing the abovementioned symptoms is urged to seek immediate medical attention.


Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news